Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/26434
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKEYTSMAN, Charly-
dc.contributor.authorBlancquaert, Laura-
dc.contributor.authorWENS, Inez-
dc.contributor.authorMissine, Maarten-
dc.contributor.authorVAN NOTEN, Pieter-
dc.contributor.authorVANDENABEELE, Frank-
dc.contributor.authorDerave, Wim-
dc.contributor.authorOP 'T EIJNDE, Bert-
dc.date.accessioned2018-07-27T10:35:24Z-
dc.date.available2018-07-27T10:35:24Z-
dc.date.issued2018-
dc.identifier.citationMULTIPLE SCLEROSIS AND RELATED DISORDERS, 21, p. 24-29-
dc.identifier.issn2211-0348-
dc.identifier.urihttp://hdl.handle.net/1942/26434-
dc.description.abstractBackground: Muscle carnosine is related to contractile function (Ca+ + handling) and buffering of exercise-induced acidosis. As these muscular functions are altered in Multiple Sclerosis (MS) it is relevant to understand muscle carnosine levels in MS. Methods: Tibialis anterior muscle carnosine was measured in an animal MS model (EAE, experimental autoimmune encephalomyelitis, n = 40) and controls (CONEX, n = 40) before and after exercise training (EAE(EX), CONEX, 10d, 1 h/d, 24 m/min treadmill running) or sedentary conditions (EAE(SED), CONSED). Human m. vastus lateralis carnosine of healthy controls (HC, n = 22) and MS patients (n = 24) was measured. Results: EAE muscle carnosine levels were decreased (p < .0001) by similar to 40% to similar to 64% at 10d and 17d following EAE induction (respectively) regardless of exercise (p = .823). Similarly, human MS muscle carnosine levels were decreased (- 25%, p = .03). Conclusion: Muscle carnosine concentrations in an animal MS model and MS patients are substantially reduced. In EAE exercise therapy does not restore this.-
dc.language.isoen-
dc.rights© 2018 Elsevier B.V. All rights reserved-
dc.subject.otherexperimental autoimmune encephalomyelitis; multiple sclerosis; carnosine; rehabilitation, muscle; neuromuscular-
dc.titleMuscle carnosine in experimental autoimmune encephalomyelitis and multiple sclerosis-
dc.typeJournal Contribution-
dc.identifier.epage29-
dc.identifier.spage24-
dc.identifier.volume21-
local.bibliographicCitation.jcatA1-
dc.description.notesKeytsman, C (reprint author), Agoralaan Bldg A, B-3590 Diepenbeek, Belgium. charly.keytsman@uhasselt.be-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.identifier.doi10.1016/j.msard.2018.02.013-
dc.identifier.isi000432725300007-
item.contributorKEYTSMAN, Charly-
item.contributorBlancquaert, Laura-
item.contributorWENS, Inez-
item.contributorMissine, Maarten-
item.contributorVAN NOTEN, Pieter-
item.contributorVANDENABEELE, Frank-
item.contributorDerave, Wim-
item.contributorOP 'T EIJNDE, Bert-
item.fullcitationKEYTSMAN, Charly; Blancquaert, Laura; WENS, Inez; Missine, Maarten; VAN NOTEN, Pieter; VANDENABEELE, Frank; Derave, Wim & OP 'T EIJNDE, Bert (2018) Muscle carnosine in experimental autoimmune encephalomyelitis and multiple sclerosis. In: MULTIPLE SCLEROSIS AND RELATED DISORDERS, 21, p. 24-29.-
item.validationecoom 2019-
item.fulltextWith Fulltext-
item.accessRightsOpen Access-
crisitem.journal.issn2211-0348-
crisitem.journal.eissn2211-0356-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
Keytsman.pdf
  Restricted Access
Published version280.56 kBAdobe PDFView/Open    Request a copy
Keytsman et al - Carnosine in EAE and MS - Clean - MSARD.pdfPeer-reviewed author version674.7 kBAdobe PDFView/Open
Show simple item record

SCOPUSTM   
Citations

14
checked on Sep 30, 2025

WEB OF SCIENCETM
Citations

13
checked on Oct 4, 2025

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.